Cancer Therapy Vol 1, page 273 Klopp CT, Alfort TC, Bateman J (1950) Fractionated intaarterial cancer chemotherapy with methyl bis amine hydrochloride: a preliminary report. Ann Surg 132, 811-832. Kreidler JF, Petzel JR (1983) Combined treatment of maxillofacial carcinoma by intra-arterial proliferation block and irradiation. Recent Results Cancer Res 86, 152-161. Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT (1997) Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 123, 978-981. Murry T, Madasu R, Martin A, Robbins KT (1998) Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 20, 31-37. Newman LA, Vieira F, Schwiezer V, Samant S, Murry T, Woodson G, Kumar P, Robbins KT (1998) Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124, 589-592. Newman LA, Robbins KT, Logemann JA, Rademaker AW, Lazarus CL, Hamner A, Tusant S, Huang CF (2002) Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck 24, 68-77. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355, 949-955. Regine WF, Valentino J, John W, Storey G, Sloan D, Kenady D, Patel P, Pulmano C, Arnold SM, Mohiuddin M (2000) Highdose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: report of a phase II study. Head Neck 22, 543-549. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB (1992) Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 14, 364-371. Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G, Howell SB (1994a) Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12, 21132120. Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri P, Kerber C, Orloff L, Los G, Howell SB (1994b) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168, 419-422. Robbins KT, Storniolo AM, Hryniuk WM, Howell SB (1996a) "Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies. Laryngoscope 106, 37-42. Robbins KT, Fontanesi J, Wong FS, Vicario D, Seagren S, Kumar P, Weisman R, Pellitteri P, Thomas JR, Flick P, Palmer R, Weir A 3rd, Kerber C, Murry T, Ferguson R, Los G, Orloff L, Howell SB (1996b) A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 122, 853-857. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB (1997) Efficacy of targeted supradose cisplatin and concomitant radiation
therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 38, 263-271. Robbins KT, Wong FS, Kumar P, Hartsell WF, Vieira F, Mullins B, Niell HB (1999a) Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125, 670-675. Robbins KT (1999b) Targeted cisplatin chemotherapy for advanced head and neck cancer. In: Eckert A (ed.) Intraarterial chemotherapy in head and neck cancer. Current results and future perspectives. Einhorn-Presse Verlag, 173182. Samant S, Kumar P, Wan J, Hanchett C, Vieira F, Murry T, Wong FS, Robbins KT (1999) Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 21, 595-601. Samant S, Robbins KT, Kumar P, Ma JZ, Vieira F, Hanchett C (2001) Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg 127, 1451-1456. Scheel JV (1981) Zur Methodik der intraarteriellen Chemotherapie maligner Tumoren im Kopf-Hals-Bereich. Laryngorhinootologie 60, 275-277. Stephens FO, Harker GJ, Crea P (1980) The intraarterial infusion of chemotherapeutic agents as "basal" treatment of cancer: evidence of increased drug activity in regionally infused tissues. Aust N Z J Surg 50, 597-602. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E 3d. (1987) Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 47, 388-393. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328, 184-194. von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight WA 3d, LeMaistre C (1986) Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. Clin Oncol 4, 1827-1834. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16, 1318-1324.
Dr. J. A. Werner
273
Dr. A. Teymoortash